A peptide (Rh-2025u) that interferes with the AR/FlnA complex was used to disrupt the cellular network around PCa-like organs, reduce biochemical changes in the ECM structure, and impair CAF migration to PCa cells (Di Donato et al., 2021). The gene discussed is AR; the disease is posterior cortical atrophy.